1. What Is the Value-Based Contracting Market?
The Value-Based Contracting Market comprises contract structures and supporting software that link pharmaceutical payments to real-world patient outcomes. It is a contracting-services and analytics-software market enabling risk sharing between manufacturers and payers. The market includes outcomes-based contracts, indication-based pricing, risk-sharing agreements, and annuity and installment payment models. Cell and gene therapy annuity-payment models addressing affordability for curative one-time treatments represent the current frontier. Scope spans outcomes-tracking analytics platforms, contract-management software, and advisory services supporting multi-party agreement implementation. These contracts govern oncology, cell and gene therapy, chronic-disease, and rare-disease drug payment arrangements between manufacturers and payers. End users include pharmaceutical manufacturers, payers and health plans, PBMs, and providers and health systems participating in risk-sharing arrangements. Pharmaceutical manufacturers, health-economics consultancies, and contracting-software vendors together design and administer value-based agreements. The scope excludes traditional rebate-only formulary contracts without outcome-performance triggers and general payer-contracting management systems.
2. Value-Based Contracting Market Size & Forecast
3. Emerging Technologies
- AI-Powered Value-Based Contracting Frameworks analyze real-time operational data streams to predict workflow demand accurately. Enterprise teams deploy automated machine learning models to accelerate processing throughput by forty percent.
- Cloud-Native Value-Based Contracting Architecture enables scalable multi-tenant asset management across distributed cloud nodes. System administrators utilize containerized microservices to lower infrastructure latency and maintain system uptime.
- Zero-Trust Value-Based Contracting Protocols enforce continuous identity verification and cryptographic encryption across all user access points. Security teams integrate automated policy enforcement software to mitigate cyber threats across enterprise networks.
- Real-Time Value-Based Contracting SDKs process high-volume transactional metrics to generate actionable business intelligence dashboards. Executive decision-makers utilize predictive telemetry feeds to optimize resource allocation and strategic planning.
Such innovations are driving change across adjacent industries too. Discover more in our Account Based Marketing Market.
4. Key Market Opportunity
A major opportunity in the Value-Based Contracting Market is automated outcome data infrastructure that tracks the clinical results value-based pharmaceutical contracts require without manual data collection burden on participating healthcare providers. Value-based pharmaceutical contracts require documented clinical outcome tracking to determine payment, but manual data collection to support these contracts places a reporting burden on provider organizations that discourages broader value-based contract participation. Outcome data infrastructure platforms from Aetion and Komodo Health are automatically extracting relevant clinical outcome data from existing electronic health record systems, satisfying contract reporting requirements without separate manual provider data entry. Payers and manufacturers using automated outcome infrastructure will reduce the provider reporting burden that has limited value-based contract adoption, and expand the number of contracts providers are willing to participate in.
5. Top Companies in the Value-Based Contracting Market
The following organisations hold leading positions in the Value-Based Contracting Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- IQVIA (Veeva)
- Medidata (Dassault)
- Oracle Clinical
- Veeva (Vault CDMS)
- Prelude Dynamics
- Saama Technologies
- Medpace
- PPD (Thermo Fisher)
- ICON
- Labcorp (Covance)
- Syneos Health
- ClinOne
- Castor
- Justification: Niche market with limited direct solution providers
6. Market Segmentation
The Value-Based Contracting Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Contract Model | Outcomes-Based Contracting Performance-Linked Rebate Contract Indication-Based Pricing Contract Risk-Sharing Contract Annuity and Installment Contract |
| By Solution Type | Value-Based Contracting Software Cloud Software On-Premise Software Value-Based Contracting Services Outcomes-Tracking Analytics |
| By Stakeholder | Manufacturer-Payer Value Contracts Standard Manufacturer-Payer Value Contracts Premium Manufacturer-Payer Value Contracts Provider Value-Based Contracts Multi-Party Value Contracts |
| By Therapy Area | Oncology Value-Based Contracts Standard Oncology Value-Based Contracts Premium Oncology Value-Based Contracts Cell-and-Gene-Therapy Contracts Chronic-Disease Value Contracts Rare-Disease Value Contracts |
| By End User | Pharmaceutical Manufacturers Large-Scale Pharmaceutical Manufacturers Mid-Size Pharmaceutical Manufacturers Payers and Health Plans PBMs Providers and Health Systems |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Value-Based Contracting Market trajectory over the forecast period:
Drug-Cost Accountability Demand Is Driving Value-Based Contracting.Tying drug payment to outcomes for cost accountability is driving value-based contracting in pharmaceutical agreements. Pfizer and payers expanded outcomes-based contracts in 2024, tying payment for high-cost therapies to demonstrated clinical outcomes.
Outcomes Measurement Is Enabling Value-Based Contracts.Real-world outcomes measurement infrastructure is enabling value-based pharmaceutical contracts by quantifying clinical outcomes. Aetion and real-world-data vendors expanded outcomes measurement in 2024 enabling value-based pharmaceutical contracts through real-world outcomes tracking.
Value-Based Contracting Is Expanding for Cell and Gene Therapies.Value-based contracting is expanding for high-cost one-time cell and gene therapies addressing payment for durable curative treatments. Novartis and payers expanded outcomes-based and installment contracts in 2024 for high-cost gene therapies addressing durable curative therapy payment.
For related market intelligence, see the Value Based Care Market.
8. Segmental Analysis
By contract model, the outcomes-based contracting segment dominated the Value-Based Contracting Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The performance-linked rebate contract segment is the fastest-growing contract model category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
By solution type, the value-based contracting software segment dominated the Value-Based Contracting Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The cloud software segment is the fastest-growing solution type category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
9. Regional Analysis
Regional demand patterns across the Value-Based Contracting Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Value-Based Contracting Market in 2025, with a market share of 48.40% of overall global revenue. Early commercial adoption of advanced technological platforms, mature enterprise infrastructure, and high regional technology spending drive market leadership. High consumer per-capita income and extensive presence of major industry solution providers reinforce ongoing dominance across the territory. The region is expected to retain its top revenue-contributing position through 2034 propelled by ongoing corporate infrastructure investments.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 12.50% during the forecast period from 2025 to 2034. Swift expansion of high-speed 5G mobile communications and surging digital infrastructure investments across China, India, and Southeast Asia fuel market expansion. Expanding urban middle-class populations and rising commercial technology adoption across developing Asian economies enable millions of new users. Regional service providers are scaling infrastructure deployments to capture expanding commercial demand across emerging Asian markets.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Value-Based Contracting Market was valued at USD 3.20 Bn in 2025 and is projected to reach USD 7.42 Bn by 2034, growing at a CAGR of 9.80% over the 2026–2034 forecast period.
The Value-Based Contracting Market is projected to grow at a CAGR of 9.80% from 2026 to 2034.
North America dominated the Value-Based Contracting Market in 2025, with a market share of 48.40% of overall global revenue.
The leading companies in the Value-Based Contracting Market include IQVIA (Veeva), Medidata (Dassault), Oracle Clinical, Veeva (Vault CDMS), Prelude Dynamics, Saama Technologies, Medpace, PPD (Thermo Fisher), ICON, Labcorp (Covance), Syneos Health, ClinOne, Castor, Justification: Niche market with limited direct solution providers.
Drug-cost accountability demand is driving value-based contracting.
By contract model, the outcomes-based contracting segment dominated the Value-Based Contracting Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.